Angiofibroma: Clinical Trials

2 trials for Angiofibroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Angiofibroma: new trials by email Literature Review of Angiofibroma trials Research Report on Angiofibroma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
Rapamune - Facial Angiofibroma
Phase 1CompletedLe Bonheur Children's Hospital112013-10-012016-08-19
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Skincerity, Skincerity plus sirolimus/rapamycin, Skinercity plus sirolimus/rapamycin - Tuberous Sclerosis, Neurofibromatoses
Phase 1CompletedThe University of Texas Health Science Center, Houston522009-12-012012-02-27

Narrower conditions

Tuberous Sclerosis (2)  ·  Neurofibroma (1)  ·  Neurofibromatoses (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hamartoma (2)  ·  Heredodegenerative Disorders, Nervous System (2)  ·  Malformations of Cortical Development (2)  ·  Malformations of Cortical Development, Group I (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Multiple Primary (2)  ·  Neoplasms, Vascular Tissue (2)  ·  Neoplastic Syndromes, Hereditary (2)  ·  Nervous System Diseases (2)  ·  Nervous System Malformations (2)  ·  Neurocutaneous Syndromes (2)

Interventions

Sirolimus (2)

Sponsors

Le Bonheur Children's Hospital (1)  ·  The University of Texas Health Science Center, Houston (1)

Countries

United States (2)

Top investigators

Hope Northrup, MD (1)  ·  James W Wheless, MD (1)  ·  Mary Kay Koenig, MD (1)

Results publications

PMID 22934754